These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 29665316)

  • 21. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
    Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
    Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and mechanism of downregulating the long-chain noncoding RNA TM4SF1-AS1 on the proliferation, apoptosis and invasion of gastric cancer cells.
    He C; Qi W; Wang Z
    World J Surg Oncol; 2021 Jul; 19(1):226. PubMed ID: 34330293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
    Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
    Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
    Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer.
    Chen T; Huang Z; Tian Y; Lin B; He R; Wang H; Ouyang P; Chen H; Wu L
    Medicine (Baltimore); 2017 May; 96(19):e6865. PubMed ID: 28489783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
    Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
    World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
    Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening.
    Zeng Z; Li Y; Zhou H; Li M; Ye J; Li D; Zhu Y; Zhang Y; Zhang X; Deng Y; Li J; Gu L; Wu J
    BMC Cancer; 2024 Jun; 24(1):773. PubMed ID: 38937694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
    Qi H; Wang Y
    Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.